Management of gram-positive coccal bacteremia and hemodialysis

American Journal of Kidney Diseases

Volumn 57, Issue 4, 2011, Pages 624-640

  Fitzgibbons, Lynn N ^a   Puls, Darcy L ^a   MacKay, Kimberly ^b   Forrest, Graeme N ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

catheter related bacteremia; dialysis accessrelated infection; Enterococcus; hemodialysis; Staphylococcus aureus

Indexed keywords

AMPICILLIN; CEFAZOLIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; NAFCILLIN; OXACILLIN; PSEUDOMONIC ACID; STAPHYLOCOCCUS VACCINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BIOFILM; BLOODSTREAM INFECTION; CATHETER CARE; CATHETER INFECTION; CATHETER REMOVAL; ECHOCARDIOGRAPHY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FLUORESCENCE IN SITU HYBRIDIZATION; HEMODIALYSIS; HUMAN; INFECTION RISK; LEUKOCYTE COUNT; LOADING DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERS, INDWELLING; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; FEMALE; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; KIDNEY FAILURE, CHRONIC; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RENAL DIALYSIS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 79952993675     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.12.013     Document Type: Article

References (173)

1. US Renal Data Systems USRDS 2009 Annual Data Report: Atlas of End Stage Renal Disease in the United States 2009 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
2. W. Greiner, A. Rasch, D. Kohler, B. Salzberger, G. Fatkenheuer, and M. Leidig Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients Clin Microbiol Infect 13 3 2007 264 268 (Pubitemid 46603356)
3. S.D. Reed, J.Y. Friedman, and J.J. Engemann Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia Infect Control Hosp Epidemiol 26 2 2005 175 183 (Pubitemid 40445023)
4. J.K. Inrig, S.D. Reed, and L.A. Szczech Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia Clin J Am Soc Nephrol 1 3 2006 518 524
5. V.G. Fowler Jr, A. Justice, and C. Moore Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia Clin Infect Dis 40 5 2005 695 703 (Pubitemid 40381343)
6. A. Servais, L. Mercadal, and F. Brossier Rapid curbing of a vancomycin-resistant Enterococcus faecium outbreak in a nephrology department Clin J Am Soc Nephrol 4 10 2009 1559 1564
7. C. Grothe, A.G. da Silva Belasco, A.R. de Cassia Bittencourt, L.A. Vianna, S.R. de Castro Cintra, and D.A. Barbosa Incidence of bloodstream infection among patients on hemodialysis by central venous catheter Rev Lat Am Enfermagem 18 1 2010 73 80
8. R. Fluck, J. Wilson, and C.R. Tomson UK Renal Registry 12th Annual Report (December 2009): chapter 12: epidemiology of methicillin resistant Staphylococcus aureus bacteraemia amongst patients receiving dialysis for established renal failure in England in 2008: a joint report from the UK Renal Registry and the Health Protection Agency Nephron Clin Pract 115 suppl 1 2010 c261 c270
9. L.A. Mermel, M. Allon, and E. Bouza Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America Clin Infect Dis 49 1 2009 1 45
10. Y. Maor, M. Hagin, N. Belausov, N. Keller, D. Ben-David, and G. Rahav Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia J Infect Dis 199 5 2009 619 624
11. P.K. Linden Optimizing therapy for vancomycin-resistant enterococci (VRE) Semin Respir Crit Care Med 28 6 2007 632 645
12. G. Taylor, D. Gravel, L. Johnston, J. Embil, D. Holton, and S. Paton Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units Infect Control Hosp Epidemiol 23 12 2002 716 720 (Pubitemid 36020207)
13. K.C. Abbott, and L.Y. Agodoa Etiology of bacterial septicemia in chronic dialysis patients in the United States Clin Nephrol 56 2 2001 124 131 (Pubitemid 32707821)
14. T.F. Saad Bacteremia associated with tunneled, cuffed hemodialysis catheters Am J Kidney Dis 34 6 1999 1114 1124
15. J.J. Engemann, J.Y. Friedman, and S.D. Reed Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis Infect Control Hosp Epidemiol 26 6 2005 534 539 (Pubitemid 40896143)
16. K.A. Marr, D.J. Sexton, P.J. Conlon, G.R. Corey, S.J. Schwab, and K.B. Kirkland Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis Ann Intern Med 127 4 1997 275 280 (Pubitemid 27352047)
17. M. Kessler, B. Hoen, D. Mayeux, D. Hestin, and C. Fontenaille Bacteremia in patients on chronic hemodialysis A multicenter prospective survey Nephron 64 1 1993 95 100 (Pubitemid 23117176)
18. S.E. Cosgrove, Y. Qi, K.S. Kaye, S. Harbarth, A.W. Karchmer, and Y. Carmeli The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges Infect Control Hosp Epidemiol 26 2 2005 166 174 (Pubitemid 40445022)
19. M.D. Danese, R.I. Griffiths, M. Dylan, H.T. Yu, R. Dubois, and A.R. Nissenson Mortality differences among organisms causing septicemia in hemodialysis patients Hemodial Int 10 1 2006 56 62 (Pubitemid 43263292)
20. Y. Li, J.Y. Friedman, and B.F. O'Neal Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients Clin J Am Soc Nephrol 4 2 2009 428 434
21. E.N. Perencevich Excess shock and mortality in Staphylococcus aureus related to methicillin resistance Clin Infect Dis 31 5 2000 1311 1313 (Pubitemid 32295473)
22. V. Ramanathan, E.J. Chiu, J.T. Thomas, A. Khan, G.M. Dolson, and R.O. Darouiche Healthcare costs associated with hemodialysis catheter-related infections: a single-center experience Infect Control Hosp Epidemiol 28 5 2007 606 609 (Pubitemid 46814554)
23. D.J. Biedenbach, G.J. Moet, and R.N. Jones Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002) Diagn Microbiol Infect Dis 50 1 2004 59 69 (Pubitemid 39360263)
24. S.K. Fridkin, J.C. Hageman, and M. Morrison Methicillin-resistant Staphylococcus aureus disease in three communities N Engl J Med 352 14 2005 1436 1444
25. R.M. Klevens, M.A. Morrison, and J. Nadle Invasive methicillin-resistant Staphylococcus aureus infections in the United States JAMA 298 15 2007 1763 1771 (Pubitemid 47598444)
26. R.M. Klevens, M.A. Morrison, and S.K. Fridkin Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors Emerg Infect Dis 12 12 2006 1991 1993 (Pubitemid 44904946)
27. C. Liu, and H.F. Chambers Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods Antimicrob Agents Chemother 47 10 2003 3040 3045 (Pubitemid 37229554)
28. F.C. Tenover, and R.C. Moellering Jr The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus Clin Infect Dis 44 9 2007 1208 1215 (Pubitemid 46651246)
29. H.S. Sader, R.N. Jones, K.L. Rossi, and M.J. Rybak Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals J Antimicrob Chemother 64 5 2009 1024 1028
30. T.P. Lodise, J. Graves, and A. Evans Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin Antimicrob Agents Chemother 52 9 2008 3315 3320
31. D.M. Sievert, J.T. Rudrik, J.B. Patel, L.C. McDonald, M.J. Wilkins, and J.C. Hageman Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006 Clin Infect Dis 46 5 2008 668 674 (Pubitemid 351321548)
32. S.E. Cosgrove, G. Sakoulas, E.N. Perencevich, M.J. Schwaber, A.W. Karchmer, and Y. Carmeli Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis Clin Infect Dis 36 1 2003 53 59 (Pubitemid 36099097)
33. Centers for Disease Control and Prevention (CDC). Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patientsUnited States, 2005 MMWR Morbid Mortal Wkly Rep 56 2007 197 199
34. T.L. Smith, M.L. Pearson, and K.R. Wilcox Emergence of vancomycin resistance in Staphylococcus aureus Glycopeptide-Intermediate Staphylococcus aureus Working Group N Engl J Med 340 7 1999 493 501
35. S.K. Pillai, G. Sakoulas, and C. Wennersten Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype J Infect Dis 186 11 2002 1603 1607 (Pubitemid 35379637)
36. S.K. Pillai, H.S. Gold, G. Sakoulas, C. Wennersten, R.C. Moellering Jr, and G.M. Eliopoulos Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF Antimicrob Agents Chemother 51 6 2007 2223 2225 (Pubitemid 46903123)
37. G.M. Sanchez, M.A. de la Torre, and G. Morales Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit JAMA 303 22 2010 2260 2264
38. V.G. Fowler Jr, J.M. Miro, and B. Hoen Staphylococcus aureus endocarditis: a consequence of medical progress JAMA 293 24 2005 3012 3021 (Pubitemid 40965071)
39. D. Kamalakannan, R.M. Pai, L.B. Johnson, J.M. Gardin, and L.D. Saravolatz Epidemiology and clinical outcomes of infective endocarditis in hemodialysis patients Ann Thorac Surg 83 6 2007 2081 2086 (Pubitemid 46805081)
40. R.G. Carrillo, J.D. Garisto, L. Salman, D. Merrill, and A. Asif Contamination of transvenous pacemaker leads due to tunneled hemodialysis catheter infection: a report of 2 cases Am J Kidney Dis 55 6 2010 1097 2101
41. G.M. Nassar, and J.C. Ayus Infectious complications of the hemodialysis access Kidney Int 60 1 2001 1 13 (Pubitemid 32587534)
42. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 3 2004 309 317 (Pubitemid 39050477)
43. J.A. Karlowsky, M.E. Jones, D.C. Draghi, C. Thornsberry, D.F. Sahm, and G.A. Volturo Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 Ann Clin Microbiol Antimicrob 3 2004 7
44. H. Shmuely, S. Pitlik, J. Yahav, Z. Samra, and L. Leibovici Seven-year study of bacteremia in hospitalized patients on chronic hemodialysis in a single tertiary hospital Ren Fail 25 4 2003 579 588 (Pubitemid 36944737)
45. E.M. D'Agata Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis Clin Infect Dis 35 10 2002 1212 1218 (Pubitemid 35305869)
46. M.P. Weinstein, M.L. Towns, and S.M. Quartey The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults Clin Infect Dis 24 4 1997 584 602 (Pubitemid 27143552)
47. J.D. Thylefors, S. Harbarth, and D. Pittet Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect Control Hosp Epidemiol 19 8 1998 581 589 (Pubitemid 128472684)
48. A. Norberg, N.C. Christopher, M.L. Ramundo, J.R. Bower, and S.A. Berman Contamination rates of blood cultures obtained by dedicated phlebotomy vs intravenous catheter JAMA 289 6 2003 726 729 (Pubitemid 37430367)
49. M.P. Weinstein Blood culture contamination: persisting problems and partial progress J Clin Microbiol 41 6 2003 2275 2278 (Pubitemid 36712422)
50. S. Kamaraju, K. Nelson, D.N. Williams, W. Ayenew, and K.S. Modi Staphylococcus lugdunensis pulmonary valve endocarditis in a patient on chronic hemodialysis Am J Nephrol 19 5 1999 605 608
51. E.M. D'Agata, D.B. Mount, V. Thayer, and W. Schaffner Hospital-acquired infections among chronic hemodialysis patients Am J Kidney Dis 35 6 2000 1083 1088 (Pubitemid 30354411)
52. R.N. Jones Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains Clin Infect Dis 42 suppl 1 2006 S13 S24
53. M.K. Spare, S.E. Tebbs, and S. Lang Genotypic and phenotypic properties of coagulase-negative staphylococci causing dialysis catheter-related sepsis J Hosp Infect 54 4 2003 272 278 (Pubitemid 37554922)
54. E.M. D'Agata, W.K. Green, G. Schulman, H. Li, Y.W. Tang, and W. Schaffner Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition Clin Infect Dis 32 1 2001 23 29 (Pubitemid 32150946)
55. G.M. Eliopoulos Aminoglycoside resistant enterococcal endocarditis Infect Dis Clin North Am 7 1 1993 117 133 (Pubitemid 23103236)
56. G.N. Forrest, M.C. Roghmann, and L.S. Toombs PNA FISH for hospital acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy Antimicrob Agents Chemother 52 10 2008 3558 3563
57. E.A. Grabsch, L.J. Burrell, A. Padiglione, J.M. O'Keeffe, S. Ballard, and M.L. Grayson Risk of environmental and healthcare worker contamination with vancomycin-resistant enterococci during outpatient procedures and hemodialysis Infect Control Hosp Epidemiol 27 3 2006 287 293
58. R. Vanholder, and S. Ringoir Polymorphonuclear cell function and infection in dialysis Kidney Int Suppl 38 1992 S91 S95
59. E.L. Pesanti Immunologic defects and vaccination in patients with chronic renal failure Infect Dis Clin North Am 15 3 2001 813 832 (Pubitemid 32852820)
60. M. Dinits-Pensy, G.N. Forrest, A.S. Cross, and M.K. Hise The use of vaccines in adult patients with renal disease Am J Kidney Dis 46 6 2005 997 1011 (Pubitemid 41690226)
61. S.J. Vandecasteele, J.R. Boelaert, and A.S. De Vriese Staphylococcus aureus infections in hemodialysis: what a nephrologist should know Clin J Am Soc Nephrol 4 8 2009 1388 1400
62. S. Pastan, J.M. Soucie, and W.M. McClellan Vascular access and increased risk of death among hemodialysis patients Kidney Int 62 2 2002 620 626 (Pubitemid 34779776)
63. J.R. Boelaert, R.F. Daneels, M.L. Schurgers, E.G. Matthys, B.Z. Gordts, and H.W. Van Landuyt Iron overload in haemodialysis patients increases the risk of bacteraemia: a prospective study Nephrol Dial Transplant 5 2 1990 130 134 (Pubitemid 20154871)
64. M.F. VandenBergh, E.P. Yzerman, B.A. van, H.A. Boelens, M. Sijmons, and H.A. Verbrugh Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state J Clin Microbiol 37 10 1999 3133 3140 (Pubitemid 29455194)
65. C. von Eiff, K. Becker, K. Machka, H. Stammer, and G. Peters Nasal carriage as a source of Staphylococcus aureus bacteremia Study Group N Engl J Med 344 1 2001 11 16 (Pubitemid 32064839)
66. H.F. Wertheim, M.C. Vos, and A. Ott Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers Lancet 364 9435 2004 703 705 (Pubitemid 39140626)
67. M. Giannella, M. Monaco, R. Nicosia, F. Chiarini, A. Pantosti, and M. Venditti A dialysis patient with bacteremia caused by a community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) carrying the staphylococcal chromosome cassette (SCC) mec type V J Chemother 20 3 2008 402 404 (Pubitemid 351998912)
68. S.R. Lederer, G. Riedelsdorf, and H. Schiffl Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients Eur J Med Res 12 7 2007 284 288 (Pubitemid 47207728)
69. H.F. Wertheim, W.B. van Leeuwen, and S. Snijders Associations between Staphylococcus aureus genotype, infection, and in-hospital mortality: a nested case-control study J Infect Dis 192 7 2005 1196 1200 (Pubitemid 41368419)
70. J. Ena, J.R. Boelaert, L.D. Boyken, H.W. Van Landuyt, C.A. Godard, and L.A. Herwaldt Epidemiology of Staphylococcus aureus infections in patients on hemodialysis Infect Control Hosp Epidemiol 15 2 1994 78 81
71. J.A. Kluytmans, and H.F. Wertheim Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections Infection 33 1 2005 3 8 (Pubitemid 40585492)
72. P.L. Lu, L.C. Chin, and C.F. Peng Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage J Clin Microbiol 43 1 2005 132 139
73. P.L. Lu, J.C. Tsai, and Y.W. Chiu Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members Nephrol Dial Transplant 23 5 2008 1659 1665
74. H.F. Wertheim, D.C. Melles, and M.C. Vos The role of nasal carriage in Staphylococcus aureus infections Lancet Infect Dis 5 12 2005 751 762 (Pubitemid 41688980)
75. W.E. Bloembergen, and F.K. Port Epidemiological perspective on infections in chronic dialysis patients Adv Ren Replace Ther 3 3 1996 201 207 (Pubitemid 26240924)
76. B. Hoen, A. Paul-Dauphin, D. Hestin, and M. Kessler EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients J Am Soc Nephrol 9 5 1998 869 876
77. J.M. Mylotte, and A. Tayara Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort Clin Infect Dis 31 5 2000 1170 1174 (Pubitemid 32295446)
78. M.J. Sarnak, and B.L. Jaber Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Kidney Int 58 4 2000 1758 1764
79. L.W. de Freitas, M.M. Neto, M.M. Nascimento, and J.F. Figueiredo Bacterial colonization in hemodialysis temporary dual lumen catheters: a prospective study Ren Fail 30 1 2008 31 35
80. C.A. Fux, D. Uehlinger, T. Bodmer, S. Droz, C. Zellweger, and K. Muhlemann Dynamics of hemodialysis catheter colonization by coagulase-negative staphylococci Infect Control Hosp Epidemiol 26 6 2005 567 574 (Pubitemid 40896147)
81. J.W. Costerton, P.S. Stewart, and E.P. Greenberg Bacterial biofilms: a common cause of persistent infections Science 284 5418 1999 1318 1322 (Pubitemid 29289651)
82. W. Zimmerli, A. Trampuz, and P.E. Ochsner Prosthetic-joint infections N Engl J Med 351 16 2004 1645 1654
83. R.O. Darouiche, and R.J. Hamill Antibiotic penetration of and bactericidal activity within endothelial cells Antimicrob Agents Chemother 38 5 1994 1059 1064 (Pubitemid 24150838)
84. W. Zimmerli, P.D. Lew, and F.A. Waldvogel Pathogenesis of foreign body infection Evidence for a local granulocyte defect J Clin Invest 73 4 1984 1191 1200 (Pubitemid 14132850)
85. R.O. Darouiche, A. Dhir, A.J. Miller, G.C. Landon, I.I. Raad, and D.M. Musher Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria J Infect Dis 170 3 1994 720 723 (Pubitemid 24262284)
86. P. Dandache, P.A. Moise, J. Orsini, M. Montecalvo, and G. Sakoulas Reduced biofilm production associated with increasing linezolid MICs among linezolid-resistant staphylococci J Antimicrob Chemother 64 5 2009 1114 1115
87. P. Pronovost, D. Needham, and S. Berenholtz An intervention to decrease catheter-related bloodstream infections in the ICU N Engl J Med 355 26 2006 2725 2732 (Pubitemid 46021509)
88. N.P. O'Grady, M. Alexander, and E.P. Dellinger Guidelines for the prevention of intravascular catheter-related infections Am J Infect Control 30 8 2002 476 489 (Pubitemid 36009080)
89. J. Merrer, J.B. De, and F. Golliot Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial JAMA 286 6 2001 700 707 (Pubitemid 33010363)
90. J.J. Parienti, M. Thirion, and B. Megarbane Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial JAMA 299 20 2008 2413 2422 (Pubitemid 351749240)
91. R.O. Darouiche, I.I. Raad, and S.O. Heard A comparison of two antimicrobial-impregnated central venous catheters Catheter Study Group N Engl J Med 340 1 1999 1 8 (Pubitemid 29024677)
92. R.O. Darouiche, D.H. Berger, and N. Khardori Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial Ann Surg 242 2 2005 193 200 (Pubitemid 41033435)
93. M. McCann, H. Einarsdottir, J.P. Van Waeleghem, F. Murphy, and J. Sedgwick Vascular access management II: AVF/AVG cannulation techniques and complications J Ren Care 35 2 2009 90 98
94. C. Pena, N. Fernandez-Sabe, and M.A. Dominguez Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization J Hosp Infect 58 1 2004 20 27 (Pubitemid 39207107)
95. D.W. Johnson, R. MacGinley, and T.D. Kay A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters Nephrol Dial Transplant 17 10 2002 1802 1807 (Pubitemid 35174293)
96. K.A. Marr Staphylococcus aureus bacteremia in patients undergoing hemodialysis Semin Dial 13 1 2000 23 29
97. R. Sesso, D. Barbosa, and I.L. Leme Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment J Am Soc Nephrol 9 6 1998 1085 1092 (Pubitemid 28264737)
98. D.W. Johnson, E.C. van, and D.W. Mudge Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients J Am Soc Nephrol 16 5 2005 1456 1462 (Pubitemid 41716531)
99. A. Levin, A.J. Mason, K.K. Jindal, I.W. Fong, and M.B. Goldstein Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine Kidney Int 40 5 1991 934 938
100. C.E. Lok, K.E. Stanley, J.E. Hux, R. Richardson, S.W. Tobe, and J. Conly Hemodialysis infection prevention with polysporin ointment J Am Soc Nephrol 14 1 2003 169 179 (Pubitemid 36026307)
101. C.W. McIntyre, L.J. Hulme, M. Taal, and R.J. Fluck Locking of tunneled hemodialysis catheters with gentamicin and heparin Kidney Int 66 2 2004 801 805 (Pubitemid 38986971)
102. L. Labriola, R. Crott, and M. Jadoul Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials Nephrol Dial Transplant 23 5 2008 1666 1672 (Pubitemid 351767750)
103. K.M. Chow, Y.L. Poon, M.P. Lam, K.L. Poon, C.C. Szeto, and P.K. Li Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients Hong Kong Med J 16 4 2010 269 274
104. Y. Jaffer, N.M. Selby, M.W. Taal, R.J. Fluck, and C.W. McIntyre A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection Am J Kidney Dis 51 2 2008 233 241
105. U.S. Nori, A. Manoharan, J. Yee, and A. Besarab Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia Am J Kidney Dis 48 4 2006 596 605 (Pubitemid 44402837)
106. A. Fattom, S. Fuller, and M. Propst Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients Vaccine 23 5 2004 656 663 (Pubitemid 39473195)
107. H. Shinefield, S. Black, and A. Fattom Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis N Engl J Med 346 7 2002 491 496 (Pubitemid 34441740)
108. R. Ruimy, M. Dos-Santos, and L. Raskine Accuracy and potential usefulness of triplex real-time PCR for improving antibiotic treatment of patients with blood cultures showing clustered gram-positive cocci on direct smears J Clin Microbiol 46 6 2008 2045 2051 (Pubitemid 351831840)
109. P.D. Stamper, M. Cai, T. Howard, S. Speser, and K.C. Carroll Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures J Clin Microbiol 45 7 2007 2191 2196 (Pubitemid 47203792)
110. G.N. Forrest, S. Mehta, E. Weekes, D.P. Lincalis, J.K. Johnson, and R.A. Venezia Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures J Antimicrob Chemother 58 1 2006 154 158 (Pubitemid 44294999)
111. K.C. Carroll Rapid diagnostics for methicillin-resistant Staphylococcus aureus: current status Mol Diagn Ther 12 1 2008 15 24 (Pubitemid 351281696)
112. G.N. Forrest PNA FISH: present and future impact on patient management Expert Rev Mol Diagn 7 3 2007 231 236 (Pubitemid 46804660)
113. T. Ly, J. Gulia, V. Pyrgos, M. Waga, and S. Shoham Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time Ther Clin Risk Manag 4 3 2008 637 640 (Pubitemid 352037904)
114. S.E. Cosgrove, and V.G. Fowler Jr Management of methicillin-resistant Staphylococcus aureus bacteremia Clin Infect Dis 46 suppl 5 2008 S386 S393
115. M.E. Stryjewski, L.A. Szczech, and D.K. Benjamin Jr Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia Clin Infect Dis 44 2 2007 190 196 (Pubitemid 46079979)
116. J.R. McDonald, L. Olaison, and D.J. Anderson Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database Am J Med 118 7 2005 759 766 (Pubitemid 40897662)
117. L.M. Baddour, W.R. Wilson, and A.S. Bayer Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America Circulation 111 23 2005 e394 e434
118. V.G. Fowler Jr, J. Li, and G.R. Corey Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients J Am Coll Cardiol 30 4 1997 1072 1078 (Pubitemid 27435904)
119. M.E. Lockhart, and M.L. Robbin Hemodialysis access ultrasound Ultrasound Q 17 3 2001 157 167 (Pubitemid 32880987)
120. K.K. Johnson, P.D. Russ, J.H. Bair, and G.D. Friefeld Diagnosis of synthetic vascular graft infection: comparison of CT and gallium scans AJR Am J Roentgenol 154 2 1990 405 409 (Pubitemid 20045280)
121. I.D. Maya, D. Carlton, E. Estrada, and M. Allon Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report Am J Kidney Dis 50 2 2007 289 295 (Pubitemid 47095070)
122. N. Fernandez-Hidalgo, B. Almirante, and R. Calleja Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study J Antimicrob Chemother 57 6 2006 1172 1180 (Pubitemid 44644422)
123. C.V. Poole, D. Carlton, L. Bimbo, and M. Allon Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen Nephrol Dial Transplant 19 5 2004 1237 1244 (Pubitemid 38628145)
124. M. Allon Dialysis catheter-related bacteremia: treatment and prophylaxis Am J Kidney Dis 44 5 2004 779 791 (Pubitemid 39445909)
125. Z. Krishnasami, D. Carlton, and L. Bimbo Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution Kidney Int 61 3 2002 1136 1142 (Pubitemid 34175482)
126. J.L. Robinson, G. Tawfik, L. Saxinger, L. Stang, W. Etches, and B. Lee Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy J Antimicrob Chemother 56 5 2005 951 953 (Pubitemid 41631925)
127. R.L. Elwood, and S.E. Spencer Successful clearance of catheter-related bloodstream infection by antibiotic lock therapy using ampicillin Ann Pharmacother 40 2 2006 347 350 (Pubitemid 43269872)
128. D.L. Landry, G.L. Braden, S.L. Gobeille, S.D. Haessler, C.K. Vaidya, and S.J. Sweet Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis Clin J Am Soc Nephrol 5 10 2010 1799 1804
129. B.J. Rijnders, W.E. Van, S.J. Vandecasteele, M. Stas, and W.E. Peetermans Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial J Antimicrob Chemother 55 1 2005 90 94 (Pubitemid 40192619)
130. G.K. Dogra, H. Herson, and B. Hutchison Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study J Am Soc Nephrol 13 8 2002 2133 2139 (Pubitemid 34790791)
131. J.M. Miro, I. Anguera, and C.H. Cabell Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database Clin Infect Dis 41 4 2005 507 514 (Pubitemid 41099645)
132. S.K. Fridkin Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know Clin Infect Dis 32 1 2001 108 115 (Pubitemid 32150955)
133. M.J. Rybak, B.M. Lomaestro, and J.C. Rotschafer Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Pharmacotherapy 29 11 2009 1275 1279
134. J.T. Kielstein, C. Eugbers, and S.M. Bode-Boeger Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysisa pharmacokinetic study Nephrol Dial Transplant 25 5 2010 1537 1541
135. P.A. Moise, E. Hershberger, M.I. Modio-Groton, and K.C. Lamp Safety and clinical outcomes when utilizing high-dose (> or = 8 mg/kg) daptomycin therapy Ann Pharmacother 43 7 2009 1211 1219
136. V.G. Fowler Jr, H.W. Boucher, and G.R. Corey Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus N Engl J Med 355 7 2006 653 665
137. B.H. Heintz, G.R. Matzke, and W.E. Dager Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal
138. B.A. Cunha, N. Mickail, and L. Eisenstein E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin Heart Lung 36 6 2007 456 461 (Pubitemid 350086682)
139. D.H. Batts, B.S. Lavin, and G.M. Eliopoulos Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapya status report Curr Clin Top Infect Dis 21 2001 227 251 (Pubitemid 33712815)
140. V.C. Wu, Y.T. Wang, and C.Y. Wang High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease Clin Infect Dis 42 1 2006 66 72
141. V. Launay-Vacher, H. Izzedine, L. Mercadal, and G. Deray Clinical review: use of vancomycin in haemodialysis patients Crit Care 6 4 2002 313 316 (Pubitemid 34863697)
142. J.T. Kielstein, J. Lorenzen, and V. Kaever Risk of underdosing of ampicillin/sulbactam in patients with acute kidney injury undergoing extended daily dialysis - a single case Nephrol Dial Transplant 24 7 2009 2283 2285
143. B. Meyer, C. Guttmann, E. Dittrich, S. Schmaldienst, and F. Thalhammer Intermittent administration of betalactam-antibiotics for treatment of severe infection in hemodialysis patients Eur J Med Res 10 4 2005 140 144 (Pubitemid 40584982)
144. R.L. Trotman, J.C. Williamson, D.M. Shoemaker, and W.L. Salzer Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy Clin Infect Dis 41 8 2005 1159 1166 (Pubitemid 41429480)
145. K.M. Sowinski, B.A. Mueller, and D.W. Grabe Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers Am J Kidney Dis 37 4 2001 766 776 (Pubitemid 32268038)
146. R.C. Moellering Jr Pharmacokinetics of vancomycin J Antimicrob Chemother 14 suppl D 1984 43 52 (Pubitemid 15075795)
147. R.H. Barth, and N. DeVincenzo Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy Kidney Int 50 3 1996 929 936 (Pubitemid 26302682)
148. R.E. Ariano, A. Fine, D.S. Sitar, S. Rexrode, and S.A. Zelenitsky Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis Am J Kidney Dis 46 4 2005 681 687 (Pubitemid 41383946)
149. L.K. Hidayat, D.I. Hsu, R. Quist, K.A. Shriner, and A. Wong-Beringer High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity Arch Intern Med 166 19 2006 2138 2144 (Pubitemid 44631403)
150. M.E. Taylor, and M. Allon Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: a single-center experience Am J Kidney Dis 55 6 2010 1163 1165
151. B.H. Dvorchik, D. Brazier, M.F. DeBruin, and R.D. Arbeit Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects Antimicrob Agents Chemother 47 4 2003 1318 1323 (Pubitemid 36368592)
152. N.N. Salama, J.H. Segal, and M.D. Churchwell Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients Nephrol Dial Transplant 25 4 2010 1279 1284
153. D. Nathwani Tigecycline: clinical evidence and formulary positioning Int J Antimicrob Agents 25 3 2005 185 192 (Pubitemid 40292746)
154. A.P. Macgowan Tigecycline pharmacokinetic/pharmacodynamic update J Antimicrob Chemother 62 suppl 1 2008 i11 i16
155. M. Aumercier, S. Bouhallab, M.L. Capmau, and G.F. Le RP 59500: a proposed mechanism for its bactericidal activity J Antimicrob Chemother 30 suppl A 1992 9 14
156. C.J. Hackbarth, H.F. Chambers, and M.A. Sande Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus Antimicrob Agents Chemother 29 4 1986 611 613 (Pubitemid 16106381)
157. M.A. Marx, R.F. Frye, G.R. Matzke, and T.A. Golper Cefazolin as empiric therapy in hemodialysis-related infections: efficacy and blood concentrations Am J Kidney Dis 32 3 1998 410 414 (Pubitemid 28411213)
158. D.N. Fusco, E.L. Alexander, and S.A. Weisenberg Clinical failure of vancomycin in a dialysis patient with methicillin-susceptible vancomycin-heteroresistant S. aureus Diagn Microbiol Infect Dis 65 2 2009 180 183
159. G. Sakoulas, J. Alder, C. Thauvin-Eliopoulos, R.C. Moellering Jr, and G.M. Eliopoulos Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin Antimicrob Agents Chemother 50 4 2006 1581 1585
160. S.E. Cosgrove, G.A. Vigliani, and V.G. Fowler Jr Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic Clin Infect Dis 48 6 2009 713 721
161. O. Korzeniowski, and M.A. Sande Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study Ann Intern Med 97 4 1982 496 503 (Pubitemid 12000691)
162. G.N. Forrest, and K. Tamura Rifampin combination therapy for nonmycobacterial infections Clin Microbiol Rev 23 1 2010 14 34
163. D.P. Levine, B.S. Fromm, and B.R. Reddy Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis Ann Intern Med 115 9 1991 674 680
164. D.J. Riedel, E. Weekes, and G.N. Forrest Addition of rifampin to standard therapy for treatment of native valve Staphylococcus aureus infective endocarditis Antimicrob Agents Chemother 52 7 2008 2463 2467 (Pubitemid 351915676)
165. M.H. Wilcox, K.J. Tack, and E. Bouza Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study Clin Infect Dis 48 2 2009 203 212
166. C. Watanakunakorn Clindamycin therapy of Staphylococcus aureus endocarditis Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin Am J Med 60 3 1976 419 425
167. A.C. Street, and D.T. Durack Experience with trimethoprim- sulfamethoxazole in treatment of infective endocarditis Rev Infect Dis 10 5 1988 915 921
168. H.W. Boucher, G.H. Talbot, and J.S. Bradley Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 1 2009 1 12
169. G.G. Zhanel, D. Calic, and F. Schweizer New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin Drugs 70 7 2010 859 886
170. T. Worthington, P.A. Lambert, and T.S. Elliott Is hospital-acquired intravascular catheter-related sepsis associated with outbreak strains of coagulase-negative staphylococci? J Hosp Infect 46 2 2000 130 134
171. C. Watanakunakorn Penicillin combined with gentamicin or streptomycin: synergism against enterococci J Infect Dis 124 6 1971 581 586
172. D.A. Figueroa, E. Mangini, and M. Modio-Groton Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program Clin Infect Dis 49 2 2009 177 180
173. A. Di Paolo, P. Malacarne, E. Guidotti, R. Danesi, and M. Del Tacca Pharmacological issues of linezolid: an updated critical review Clin Pharmacokinet 49 7 2010 439 447